Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pregnancy Trimester, First | 1 | 2020 | 366 | 0.73 | Why? |
| Tuberculosis, Meningeal | 1 | 2018 | 100 | 0.65 | Why? |
| Herpesvirus 6, Human | 1 | 2018 | 162 | 0.62 | Why? |
| Enterovirus | 1 | 2018 | 402 | 0.54 | Why? |
| Enterovirus Infections | 1 | 2018 | 404 | 0.51 | Why? |
| Immunoglobulin G | 5 | 2021 | 21571 | 0.41 | Why? |
| Antibodies, Viral | 6 | 2021 | 51949 | 0.26 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.26 | Why? |
| Metagenomics | 2 | 2019 | 823 | 0.25 | Why? |
| Cross Infection | 1 | 2021 | 8675 | 0.19 | Why? |
| Lassa virus | 1 | 2019 | 99 | 0.18 | Why? |
| Lassa Fever | 1 | 2019 | 88 | 0.17 | Why? |
| Prenatal Diagnosis | 1 | 2020 | 345 | 0.17 | Why? |
| Antibody Formation | 2 | 2021 | 4038 | 0.17 | Why? |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 314 | 0.17 | Why? |
| Health Personnel | 5 | 2021 | 29646 | 0.17 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.16 | Why? |
| Single-Blind Method | 1 | 2020 | 1283 | 0.16 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.15 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.14 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.14 | Why? |
| Molecular Epidemiology | 1 | 2019 | 1638 | 0.12 | Why? |
| Bayes Theorem | 1 | 2021 | 3237 | 0.11 | Why? |
| England | 2 | 2020 | 5116 | 0.11 | Why? |
| Orthomyxoviridae | 1 | 2019 | 1168 | 0.11 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.11 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.10 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2018 | 1439 | 0.10 | Why? |
| United Kingdom | 4 | 2021 | 18046 | 0.09 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.09 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.08 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2021 | 1969 | 0.08 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.07 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.07 | Why? |
| Antibodies, Monoclonal | 2 | 2021 | 8041 | 0.07 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.06 | Why? |
| Adult | 7 | 2021 | 244371 | 0.06 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.06 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.06 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.06 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.05 | Why? |
| Humans | 14 | 2021 | 930598 | 0.05 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.05 | Why? |
| CHO Cells | 1 | 2021 | 831 | 0.05 | Why? |
| Cricetulus | 1 | 2021 | 936 | 0.04 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.04 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.04 | Why? |
| HEK293 Cells | 2 | 2021 | 8394 | 0.04 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.04 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.04 | Why? |
| Blood Glucose Self-Monitoring | 1 | 2021 | 791 | 0.04 | Why? |
| Female | 6 | 2021 | 380317 | 0.04 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.04 | Why? |
| Influenza, Human | 1 | 2019 | 10779 | 0.04 | Why? |
| Structure-Activity Relationship | 1 | 2021 | 2219 | 0.03 | Why? |
| Vero Cells | 2 | 2021 | 14117 | 0.03 | Why? |
| Protein Binding | 2 | 2021 | 11430 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2021 | 2437 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.03 | Why? |
| Ageusia | 1 | 2021 | 918 | 0.03 | Why? |
| RNA Viruses | 1 | 2019 | 824 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2020 | 1609 | 0.03 | Why? |
| Asymptomatic Infections | 2 | 2021 | 7218 | 0.03 | Why? |
| Nigeria | 1 | 2019 | 2292 | 0.03 | Why? |
| Phylogeny | 2 | 2019 | 13341 | 0.03 | Why? |
| Male | 5 | 2021 | 367725 | 0.03 | Why? |
| Aged | 3 | 2021 | 215776 | 0.02 | Why? |
| Child | 1 | 2018 | 70012 | 0.02 | Why? |
| Hypoglycemic Agents | 1 | 2021 | 2165 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 3633 | 0.02 | Why? |
| State Medicine | 1 | 2021 | 2847 | 0.02 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.02 | Why? |
| Genome, Viral | 2 | 2019 | 13157 | 0.02 | Why? |
| Blood Glucose | 1 | 2021 | 3642 | 0.02 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
| Animals | 3 | 2021 | 78931 | 0.02 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.02 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.02 | Why? |
| Zoonoses | 1 | 2019 | 3034 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Computational Biology | 1 | 2019 | 4514 | 0.02 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2021 | 7330 | 0.01 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.01 | Why? |
| RNA, Viral | 1 | 2019 | 32276 | 0.01 | Why? |
Lumley's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(93)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(198)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_